Pandemic – Randy Bock MD PC

In May 2026, a wildlife expedition cruise ship called the MV Hondius departed Argentina carrying roughly 150 passengers bound for Antarctica. Within days, a handful of travelers who had hiked in rodent-inhabited mountain terrain fell gravely ill. By the time the ship made port, two had died, a third death was suspected, and eleven passengers total were linked to the Andes strain of hantavirus — the only hantavirus known to transmit person to person.

It should have been a regional public health notice. Instead, it became a global media event.

Warships were dispatched to remote Atlantic islands. Biocontainment units across three continents activated. Wire services led with breathless dispatches for days. And social media lit up with one burning question: Is this the next COVID?

In a recent interview, Dr. David Bell — physician, epidemiologist, former WHO staffer of nine years, and one of the more outspoken critics of the global pandemic-preparedness industrial complex — offered a very different question: Who benefits from the panic?

• What Is Hantavirus — and How Serious Is the 2026 Outbreak, Really?
• A Pattern Worth Recognizing: The Outbreak Carousel
• The WHO Pandemic Treaty: Still Struggling, Still Necessary to Sell
• The mRNA Vaccine Angle: Marketing a Product Without a Market
• How the WHO’s Funding Model Changed Everything
• The Real Cost: What Doesn’t Make the Headlines
• Vaccines as Medicine, Not Mandates
• What Would Actually Help
• The Bottom Line on Hantavirus 2026
• FAQs
  • Q1: Is the hantavirus outbreak 2026 a pandemic risk to the general public?
  • Q2: Why did the 2026 hantavirus outbreak get so much media coverage if it wasn’t a major threat?
  • Q3: What is the WHO pandemic treaty, and why is it controversial?
  • Q4: How does the mRNA hantavirus vaccine connect to the media coverage of the 2026 outbreak?
  • Q5: What does Dr. David Bell recommend instead of pandemic preparedness spending?

Before unpacking the politics, the science deserves a fair hearing.

Hantaviruses spread primarily through inhalation of aerosolized rodent droppings, urine, or saliva. The Andes variant — endemic to South America — is unique in that it can, under conditions of prolonged close contact, spread from person to person. Nurses caring for severely ill patients have contracted it. Household members sharing beds with infected partners have gotten sick. But casual transmission in public settings has never been documented.

The hantavirus outbreak 2026 aboard the MV Hondius produced 8 confirmed cases, 3 more suspected, and 2–3 deaths among 150 people confined together for weeks in the South Atlantic. That is a meaningful but contained cluster — not an exponential spread event.

More telling: population surveys in rural South America show that over 1% of residents — and many people who keep pet mice — carry hantavirus antibodies, meaning they were exposed and their immune systems handled it without hospitalization. The hospitalization fatality rate is high, but that reflects who gets counted, not the full picture of infection. Most exposures appear to be mild or completely silent.

The WHO estimates 10,000–100,000 hantavirus cases occur globally each year, including several thousand in Europe. This is not a new pathogen. It has not mutated into something novel. The genome sequenced from the cruise ship cluster is consistent with a 2018 isolate and shows the expected rate of natural mutation. No lab-origin theory holds water.

So why did it dominate the news cycle for weeks?

Dr. Bell describes what he calls a recurring carousel of “petty plagues” — small outbreaks inflated into existential threats:

Compare these numbers to the diseases that kill people every single day without front-page coverage:

The disparity is not an accident of newsworthiness. It reflects something structural about how the global health agenda is now set — and who funds it.

At the time of the MV Hondius outbreak, the WHO was in the middle of yet another attempt to finalize its pandemic agreement — specifically, the Pathogen Access and Benefit-Sharing (PABS) annex, the section dealing with how countries share disease samples and receive equitable access to resulting vaccines and treatments.

The agreement has been stalling for years. African nations in particular have pushed back, questioning whether signing on delivers genuine equity or merely locks them into a system that funnels public money toward Western pharmaceutical production lines while their own health systems remain underfunded.

For the pandemic preparedness agenda to move forward, the argument needs to feel urgent. Outbreaks that stay in the news help that argument. Outbreaks that quietly resolve in a fishing village in rural Chile do not.

Bell’s pointed observation: once a story is placed with Reuters or AP, it becomes a global story automatically, because virtually every downstream outlet sources from them. The question isn’t why the MV Hondius story ran everywhere. The question is why it was placed prominently enough to run everywhere in the first place.

Here is where the commercial dimension becomes impossible to ignore.

Moderna — the mRNA vaccine company that became a household name during COVID-19 — has been working with a South Korean partner to develop an mRNA-based hantavirus vaccine. The scientific challenge of developing such a vaccine is real. The commercial challenge is more pressing: hantavirus has historically been so rare in public consciousness that there is essentially no demand for a vaccine against it.

Vaccines, as Bell explains, represent an ideal commercial model compared to, say, antibiotics. You give an antibiotic only to someone with a confirmed infection. A vaccine, in theory, goes to everyone — healthy adults, children, elderly — and may require multiple doses, boosters, and eventually mandates to maximize the addressable market. As mRNA technology has matured, the marginal cost of producing a new vaccine from a pathogen’s genetic sequence has dropped dramatically. The bottleneck is no longer manufacturing. It is demand.

Creating demand for a product no one feared requires making people afraid of the underlying disease. A cruise ship outbreak, with its built-in drama of isolation, repatriation flights, biocontainment units, and tearful passengers in hazmat-zone footage, is — at minimum — extremely fortuitous timing.

The WHO that Dr. Bell joined in the 2000s was an institution funded primarily by member states, which gave the secretariat significant discretion over how to allocate resources based on technical need and public health evidence.

That institution no longer exists.

Today, approximately 80% of WHO funding is “specified” — meaning donors earmark it for particular programs. The largest individual donor to the WHO is Bill Gates, who holds substantial private investments in vaccine-related companies and funds. The second largest is GAVI, the vaccine alliance (established around 2001), a public-private partnership whose explicit mandate is to accelerate global vaccine uptake. CEPI — the Coalition for Epidemic Preparedness Innovations, founded in 2017, a century after the Spanish flu — focuses almost entirely on pandemic vaccines and outbreak-response products.

The cumulative result: an institution once tasked with improving health outcomes in low-income countries by fighting malaria, tuberculosis, childhood malnutrition, and sanitation deficits is now substantially organized around emergency outbreak response — the one area most lucrative to pharmaceutical manufacturers.

The proposed budget for pandemic preparedness infrastructure is approximately $31 billion per year — nearly ten times the WHO’s total annual operating budget. The beneficiaries of that spending are overwhelmingly Western pharmaceutical corporations and the global health bureaucracy that orbits them.

Every dollar diverted toward theoretical pandemic preparedness for diseases that infect hundreds — or even thousands — is a dollar not spent on the diseases that kill millions.

COVID-era debt has already produced measurable downstream harm: African nations that borrowed heavily to respond to COVID-19 have since reduced their domestic health spending. Nutrition funding globally has contracted. The number of children dying of malaria is increasing. Tuberculosis case fatality rates are rising as treatment programs are squeezed.

As Bell frames it: the fear machine doesn’t just waste money. It actively makes things worse. Poverty is the primary driver of infectious disease severity. Malnourished children die of MPOX; well-nourished children typically do not. People with healthy immune systems and access to early supportive care survive hantavirus; people without those things often don’t. The pandemic-preparedness industrial complex diverts resources precisely away from the poverty-reduction investments that would do the most to reduce future outbreak mortality — and redirects them toward product pipelines that may never be needed.

It would be reductive to read Bell’s critique as anti-vaccine absolutism. His position is more precise and, arguably, more defensible: vaccines should be evaluated the way any other medicine is evaluated — on an individual cost-benefit basis for the specific patient in front of you.

A newborn in a hepatitis B-negative household in a small North American town does not need a hep-B vaccine on day one of life. A physician working in rural Philippines, where rabies is endemic and post-exposure prophylaxis may be unavailable, should absolutely get vaccinated against rabies. The question is not whether vaccines work. It is whether the mandate-and-mandate-everything model serves public health — or serves revenue targets.

The pandemic treaty, as currently envisioned, would institutionalize the COVID response model globally: mass vaccination campaigns regardless of risk stratification, emergency authorities that override normal regulatory scrutiny, and surveillance infrastructure that benefits the donors who fund it. Bell’s assessment: it will likely do more net harm than good.

The conversation between Bell and host Randy Bock ultimately circles back to something unglamorous and difficult to monetize: economic development.

Hong Kong — a city with no natural resources and an airport famously difficult to land at — became wealthier and healthier than Tanzania, which has fertile land, mineral wealth, beaches, and an educated workforce, because Hong Kong made it possible to start a business in an afternoon. Tanzania, at least historically, burdened entrepreneurs with years of bureaucratic obstacles and corruption at every step.

The same principle applies to global health. Clean water reaches people when economies produce the infrastructure to deliver it. Surgeons wash their hands when hospitals have the equipment and culture to expect it. Malaria kills fewer children when primary care systems can test and treat in the same visit. None of this requires a $31-billion-a-year pandemic preparedness budget. It requires conditions under which countries can build functioning health systems — which begins with debt relief, fair trade, and stopping the deliberate destabilization of resource-rich low-income economies for extraction purposes.

Those are harder problems than sequencing a pathogen and printing an mRNA vaccine. They don’t produce quarterly earnings reports. And they require confronting interests far more powerful than a rodent-borne virus on a cruise ship.

The MV Hondius outbreak was real. The people who died were real tragedies. The Andes hantavirus is a genuine disease that kills people who encounter it without adequate medical support.

It was never going to become a global pandemic. Its own biology — the close-contact requirement, the lack of airborne transmission at scale, the immune clearance that most exposed people experience silently — makes that extremely unlikely. Even WHO epidemiologists said as much during the peak of the media coverage.

What it was — and what Bell argues convincingly — is a case study in how the infrastructure of pandemic fear now operates: which stories get amplified, why certain outbreaks become international incidents while others are ignored, and who stands to benefit when the public believes the next existential pathogen is always just one cruise ship away.

Understanding that machinery isn’t conspiracy thinking. It’s public health literacy.

No. Both the CDC and WHO have confirmed that the overall risk to the general public from the 2026 hantavirus outbreak is extremely low. The Andes virus — the strain involved in the MV Hondius cruise ship cluster — requires prolonged, close physical contact to spread person to person. Unlike COVID-19, it has no demonstrated airborne transmission at scale. Of 150 passengers confined together for weeks on the ship, only 11 cases were confirmed or suspected. Epidemiologists do not expect this outbreak to trigger community spread in any country.

That is exactly the question Dr. David Bell, former WHO adviser, raises in this interview. Hantavirus causes an estimated 10,000–100,000 cases globally every year with little media attention. The MV Hondius outbreak — involving 11 cases and 2–3 deaths — became an international story almost overnight. Bell points to two converging factors: the WHO’s ongoing struggle to finalize its pandemic treaty, which requires sustained public concern about outbreak risk to build political momentum, and the active development of an mRNA hantavirus vaccine by Moderna — a product that needs a fearful public to create market demand.

The WHO Pandemic Agreement is an international framework intended to coordinate global responses to future pandemics, including pathogen sharing, vaccine distribution, and emergency health authorities. The Pathogen Access and Benefit-Sharing (PABS) annex — the most contested section — determines how countries share disease samples and receive equitable access to resulting vaccines and treatments. Critics, including many African nations, argue the treaty disproportionately benefits Western pharmaceutical manufacturers while locking low-income countries into a system that drains resources from proven health interventions like malaria and tuberculosis treatment. As of mid-2026, the PABS annex remains unfinalized.

Moderna has been developing an mRNA-based hantavirus vaccine in partnership with a South Korean research group. The commercial challenge is significant: hantavirus has historically been so obscure that consumer demand for a vaccine against it is essentially nonexistent. mRNA vaccines are most profitable when administered broadly — ideally to entire populations, with boosters, and eventually under mandate. Without public fear of the underlying disease, the return on investment for such a product is extremely difficult to justify. A highly publicized cruise ship outbreak, with repatriation flights and biocontainment footage, provides exactly the kind of visibility that transforms an obscure pathogen into a household concern.

Bell argues that the single most effective investment in global health is economic development in low- and middle-income countries — not emergency outbreak infrastructure. Clean water, functioning primary care systems, nutrition support, and debt relief do more to reduce infectious disease mortality than $31-billion-a-year pandemic preparedness budgets. He points out that people die from diseases like MPOX, malaria, and tuberculosis primarily because of poverty and malnutrition — not because vaccines or surveillance systems are unavailable. The pandemic-preparedness model, in his view, diverts public money toward pharmaceutical production lines while the interventions that would most reduce suffering remain chronically underfunded.

The COVID-19 pandemic policy failure may be one of the most consequential and least examined crises of our time. Professor Garrett Wallace Brown — a health economist who sat inside the UK Cabinet Office and WHO committees during the early months of 2020 — argues that those entrusted with global health security had no coherent plan, no reliable evidence base, and no accountability for the decisions that shuttered economies and cost trillions. His REPPARE project now offers a systematic, evidence-based reckoning with what went wrong — and what must change before the next outbreak.

The early months of the COVID-19 pandemic revealed a disturbing truth: those tasked with protecting global health security had “no idea what they were doing.” This assessment comes not from an outside critic, but from Professor Garrett Wallace Brown, a health economist who sat inside the UK Cabinet Office and WHO committees during the crisis.

What Brown witnessed during those critical first weeks of 2020 should concern anyone interested in pandemic preparedness and global health security. Politicians grasped for certainty amid chaos, choosing the most frightening projections under a dangerous doctrine called “no regrets.” The result? Trillions spent, economies shuttered, and a pandemic response architecture built on flawed assumptions that persists today.

• The Reckoning: Inside the COVID-19 Pandemic Policy Failure With Garrett Wallace Brown
• The REPPARE Project: Exposing Flawed Pandemic Risk Assessments
• Inflated Risk: The Evidence Doesn’t Support the Alarm
• The Economics Don’t Add Up: Pandemic Preparedness Cost Models Under Scrutiny
• The “No Regrets” Policy: How Fear Overrode Evidence
• A One-Trick Pony: The Over-Biomedicalization of Pandemic Response
• The Mpox Example: Misplaced Priorities in Action
• WHO’s Pandemic Response Reversal: Following the Crowd
• China’s Outsized Influence on Global Health Governance
• Entrenched Paradigms: Why Reform Faces an Uphill Battle
• A Path Forward: Evidence-Based Pandemic Preparedness
• Key Reform Priorities:
  • 1. Realistic Risk Assessment
  • 2. Honest Cost-Benefit Analysis
  • 3. Balanced Health System Approach
  • 4. Diverse Intervention Portfolio
  • 5. Transparent Governance
• Lessons for Future Health Emergencies
• The Stakes for Global Health Security
• About the REPPARE Project
  • Key Publications:
• Related Resources, Videos, and Links

Brown’s journey from health economics researcher to pandemic policy critic began with a simple question: How did the WHO and World Bank calculate pandemic preparedness costs? When asked to contribute data for a major preparedness cost analysis, he discovered something troubling—the inputs didn’t match the outputs, and officials couldn’t (or wouldn’t) explain their methodology.

This sparked the REPPARE project (Re-Evaluating Pandemic Preparedness and Response), a comprehensive three-year investigation examining post-COVID pandemic preparedness policy. What the research team found challenges virtually every assumption driving current global health security investments.

Current WHO pandemic risk assessments claim a major pandemic is “highly likely” within 20-40 years. The problem? This conclusion misquotes the very research it cites.

The Mariani study referenced by WHO actually estimates a COVID-scale event every 209 years, not 20-40 years. Brown’s team found this pattern repeatedly—severity models leaning heavily on the 1918 Spanish flu (which occurred before antibiotics and amid a world war), while ignoring crucial context.

Most importantly, none of these pandemic risk models account for the explosion in diagnostic capacity since 1983, when PCR testing revolutionized pathogen detection. As Brown explains: “Our diagnostic and surveillance capacities have increased exactly along the same curve as the number of new pathogens or outbreaks reported.”

When adjusted for improved detection capabilities, the trend for natural spillover events is actually downward—with COVID-19 representing an outlier, not a trend.

The financial projections driving pandemic preparedness are equally problematic. Brown’s analysis of WHO and World Bank cost estimates revealed:

“No one in their right mind would say that,” Brown notes. The moment an outbreak spreads beyond a small population, economic costs are inevitable. Yet return-on-investment calculations for pandemic preparedness assume perfect prevention—a fantasy that inflates the perceived value of current spending.

Consider the UK’s “Eat Out to Help Out” scheme, which cost billions to encourage restaurant dining after lockdowns. This wasn’t a necessary pandemic response cost—it was an expensive fix for self-inflicted economic damage. Yet such indirect costs are lumped together with legitimate pandemic expenses, artificially inflating the economic case for current preparedness strategies.

Inside UK Cabinet meetings, Brown observed a consistent pattern. Officials presented five epidemiological models weekly—none optimistic, most catastrophic. Politicians invariably chose the worst-case scenario, operating under what they called “no regrets” doctrine: better to overreact than risk blame for underreaction.

This approach explains why countries overbought PPE, overbought vaccines, and implemented extreme measures despite limited supporting evidence. Neil Ferguson’s Imperial College projections consistently showed the most frightening outcomes and received disproportionate weight, despite questions from the Office of National Statistics about inflated estimates.

The evidence was there for a different approach. Diamond Princess cruise ship data clearly showed age-stratified risk. The French aircraft carrier Charles de Gaulle demonstrated minimal impact on young, healthy military populations. Yet this nuanced evidence was “largely ignored” in favor of population-wide panic measures.

Perhaps most concerning is the governance structure emerging from COVID-19. Every major institution created or empowered—the Pandemic Fund, the 100-Day Vaccine Mission, the German BioHub, new countermeasure distribution systems—follows the same narrow playbook:

“It’s a one-trick pony,” Brown warns. This biomedicalized approach ignores the real killers claiming millions annually: tuberculosis (1.3 million deaths per year), malaria (47,000 children dead annually in DRC alone), and basic health system weaknesses.

The WHO’s priority pathogen list—including the mysterious “Disease X”—accounts for just 17,000 total historical deaths across all listed diseases combined. Yet these rare exotic threats receive disproportionate attention and resources compared to endemic diseases with massive proven impacts.

The recent Mpox response in Democratic Republic of Congo illustrates this misallocation. With 55 deaths from Mpox (spread primarily through direct contact, not airborne transmission), the international response allocated resources equivalent to $1.2 million per life saved.

Meanwhile, 47,000 children die from malaria in DRC annually, and basic health clinics lack reliable electricity. As Brown pointedly asks: “You can’t keep the lights on in your clinics and you’re going to spend 1.2 million per life saved?”

Brown’s findings on WHO behavior during COVID-19 reveal an organization that followed rather than led. The WHO’s 2019 “Managing Epidemics” handbook explicitly advised against:

Yet by 2022, the second edition normalized all these interventions. What changed? Not the evidence—the WHO simply adapted its guidance to match what countries were already doing, likely to preserve institutional authority after being ignored during the crisis.

Brown identifies a troubling dynamic in UN health agencies: dependence on China’s development statistics to demonstrate global progress. China’s dramatic poverty reduction has masked stagnation elsewhere, creating perverse incentives.

“If you want to see progress towards your UN goals, you get China to do it,” Brown observes. This dependency may explain the WHO’s deference to Chinese authorities during early pandemic response, when critical information sharing lagged.

Despite clear evidence of pandemic policy failures, changing course remains difficult. Brown identifies a “bad cocktail” of factors perpetuating the status quo:

Having participated in G7 and G20 meetings five times each and sat on WHO subcommittees, Brown understands how these forces operate. “Politicians are told things, they don’t even know if it’s right or wrong. They’re just told.”

The REPPARE project doesn’t argue against pandemic preparedness—it argues for honest, evidence-based preparedness that doesn’t sacrifice known solutions for hypothetical threats.

Brown’s Swedish-style recommendations during COVID-19—protecting the vulnerable, avoiding long lockdowns, keeping schools open—were derided as reckless at the time but have since been largely vindicated. His warnings against putting “all our eggs in one basket” with vaccination-only strategies proved prescient as variants emerged and vaccine effectiveness against transmission disappointed.

The core lesson isn’t that preparation is unnecessary—it’s that panic-driven preparation creates its own catastrophe. As Brown told his wife after that first Cabinet meeting: “These people have no idea what they’re doing.”

Five years later, with pandemic preparedness architecture firmly entrenched, the question remains: Will evidence matter more than fear next time?

The decisions made now about pandemic preparedness will shape global health for decades. Every dollar directed toward hypothetical exotic pathogens is a dollar not spent on tuberculosis, malaria, maternal health, or strengthening fragile health systems in low-resource settings.

Brown’s research suggests we’re building the wrong architecture—securitized, biomedicalized, and unmoored from evidence. The paradigms are strong, the interests entrenched, but the possibility of course correction exists if political will can be mustered.

“Maybe it’s hope before reality,” Brown acknowledges. But with projects like REPPARE forcing honesty about pandemic evidence, costs, and priorities, there’s a chance to “repair” what went wrong before the next panic takes hold.

The REPPARE project (Re-Evaluating Pandemic Preparedness and Response) is a three-year research initiative examining post-COVID pandemic policy and governance. Led by Professor Garrett Wallace Brown at Leeds University, the project has published 15+ academic articles in major journals including The Lancet, with comprehensive reports on zoonotic risk, cost and financing, and governance architecture.

For researchers, policymakers, and public health professionals seeking evidence-based pandemic preparedness strategies, the REPPARE findings offer crucial insights into building more effective, proportionate, and accountable health security systems for future global health emergencies.

https://www.americaoutloud.news/garrett-wallace-brown-on-pandemic-policy-failure/

https://essl.leeds.ac.uk/politics/staff/64/professor-garrett-wallace-brown

https://essl.leeds.ac.uk/directories0/dir-record/research-projects/1260/re-evaluating-the-pandemic-preparedness-and-response-agenda-reppare

Pandemic preparedness funding has grown into a $30–40 billion annual industry—ten times the entire WHO operating budget. Dr. David Bell, a former WHO physician now leading the REPPARE Project at the University of Leeds, has spent years reviewing the data behind these investments. His conclusion is troubling: the money is not flowing toward the world’s deadliest diseases. Instead, it is being channeled through public-private partnerships that serve pharmaceutical shareholders, institutional bureaucracies, and fear-driven narratives—not the populations most in need.

• Pandemic Preparedness Funding Exposed: Is the Industry Built on Fear?
  • The Rise of Pandemic Preparedness Funding: Follow the Money
    • WHO Pandemic Agreement: A New Financial Architecture
    • Gates Foundation and the Global Health Funding Machine
  • REPPARE Project: What the Evidence Actually Shows
    • WHO’s Priority Disease List Under the Microscope
    • The COVID Data Inflation Scandal
    • Their methodology assumes:
  • Why Pandemic Preparedness Funding Doesn’t Fix Real Health Crises
    • Pandemic Preparedness as Revenue Stream
    • The Pandemic Fund and Global Health Security
  • Academic Capture: When Health Science Becomes Marketing
  • Climate Change: The Perfect Partner Narrative
  • The Path Forward: Restoring Integrity to Global Health Funding
    • Why REPPARE Matters
    • Real Threats Left Behind While Pandemic Budgets Balloon
  • Conclusion: Admitting the Problem Before Finding the Answer
  • FAQ’s
    • What is pandemic preparedness funding?
    • Who controls WHO’s pandemic budget?
    • What is the REPPARE Project?
  • Key Takeaways
  • About REPPARE and Dr. David Bell

The pandemic preparedness narrative has reached fever pitch. The World Bank and WHO speak of “existential threats” requiring $30-40 billion annually—ten times WHO’s current total budget. In May 2025, the WHO Pandemic Agreement was formally adopted after three years of negotiation, cementing this new financial architecture.

But here’s what most people don’t know: WHO’s funding structure has fundamentally changed. Bell explains that 80% of WHO funding is now earmarked by specific donors for specific projects—a radical departure from the pooled country contributions that once gave the organization independence.

The Gates Foundation has become WHO’s largest single funder, surpassing even the United States following America’s announced withdrawal in 2025. Between 2000 and 2024, the Foundation donated $5.5 billion to WHO—with over 50% directed toward vaccines and polio programs.

As Bell notes with measured concern: “A company can only participate significantly in a public-private partnership if they think they’ll make money out of it.” This isn’t conspiracy—it’s basic economics. When pharmaceutical representatives sit on boards deciding how to spend public money, they fulfill their fiduciary duty to shareholders, not global health needs.

Bell’s team scrutinized WHO’s R&D Blueprint—the list of diseases supposedly threatening humanity. The findings are remarkable:

“There is nothing on that list that would logically cause you much concern,” Bell states. “Infectious disease deaths have been declining for a century.”

Perhaps REPPARE’s most explosive finding concerns how COVID deaths are being counted for posterity. The Institute for Health Metrics and Evaluation (IHME)—funded by the Gates Foundation and considered the “gold standard” for disease burden data—has created models that systematically inflate COVID deaths while minimizing collateral damage from lockdowns and vaccines.

Using these assumptions, IHME converts the 15.9 million excess deaths during 2020-2021 into predominantly COVID deaths, particularly in African nations with low vaccination rates. As Bell warns: “We’re building a false history. Someday people will believe these numbers are real.”

Bell doesn’t speak in conspiratorial whispers. He speaks with the resignation of someone who understands bureaucratic incentives:

“If you’re running a research lab, your main concern is making sure your staff don’t get sacked because you run out of money. If there’s $200 million earmarked for Zika vaccine research, you’ll work on Zika—not because we need it, but because the funding is there.”

The same logic applies throughout the system:

The World Bank’s Pandemic Fund, established in 2022, has awarded $885 million in grants, catalyzing over $6 billion in total resources across 75 countries. While proponents celebrate this investment in global health security, critics like Bell ask: investment in what, exactly?

When malaria kills far more people annually than any disease on WHO’s priority list, when tuberculosis and HIV remain major killers, when basic sanitation would prevent millions of deaths—why are we directing resources toward theoretical pandemics?

Bell is candid about the systemic problem: “Science has become marketing. Almost all nutrition research is funded by food companies. Almost all health research is funded by pharmaceutical ones. You get the results the sponsors want.”

The Neil Ferguson example is instructive. His Imperial College models predicted 500,000 UK deaths and 3 million US deaths from COVID—projections that justified lockdowns and eventually vaccine mandates. At the same time, Ferguson co-authored a Lancet paper showing almost no one under 65 died from COVID.

“Did he publish contradictory data?” one might ask. Yes. “Did it matter?” Apparently not when funding comes from interested parties.

The WHO now officially claims climate change is “driving” malaria increases, despite evidence pointing to drug resistance, insecticide resistance, poverty, and civil war. Meanwhile, malaria is being successfully eliminated in temperate countries—exactly where climate warming should theoretically have the greatest impact.

As Bell observes: “If you’re doing vaccines, you will work on Zika not because we need a Zika vaccine but because there is $200 million sitting there waiting.”

The same dynamic applies to climate-pandemic linkages. Once you establish climate change as an amplifier of infectious disease risk, you unlock additional funding streams. The science becomes secondary to the narrative that unlocks resources.

Bell remains guardedly hopeful, citing universities like Leeds that still “permit integrity” and organizations like Brownstone Institute that fund independent research without demanding predetermined outcomes.

The REPPARE Project’s methodology is simple but powerful: examine the evidence that institutions like WHO, World Bank, and G20 use to justify their claims. Don’t accept consensus. Don’t defer to authority. Check the citations.

What they’ve found repeatedly: institutional claims contradict their own cited evidence.

While billions flow toward pandemic preparedness, the actual killers receive inadequate attention:

“We still have major problems in real health,” Bell emphasizes, “and billions are wasted chasing phantoms.”

Dr. David Bell’s message is both sobering and essential: we have to start admitting the problem before we can find the answer.

The pandemic industry has created a self-reinforcing cycle where:

Breaking this cycle requires what Bell and REPPARE are doing: meticulous evidence review, intellectual honesty, and the courage to challenge powerful institutions.

As Bell concludes: “The incentives are wrong. The system rewards fear.” Until we realign incentives toward actual health outcomes rather than theoretical catastrophes, global health will remain captured by profit and politics.

The question isn’t whether another pandemic will come. The question is whether we’ll use public resources to address real health needs—or continue feeding an industry built on manufactured fear.

Pandemic preparedness funding refers to the financial resources allocated by governments, international institutions, and private donors to prevent, detect, and respond to infectious disease outbreaks before they become global crises. In recent years, this funding has grown dramatically — the World Bank and WHO now call for $30–40 billion annually to be directed toward pandemic preparedness infrastructure, surveillance systems, and vaccine development programs. Critics, including researchers at the REPPARE Project, argue that pandemic preparedness funding is increasingly misallocated toward theoretical disease threats and pharmaceutical-aligned priorities, while proven killers like malaria, tuberculosis, and unsafe water — which claim millions of lives every year — remain chronically underfunded.

WHO’s pandemic budget is no longer controlled primarily by member states. Today, approximately 80% of WHO’s funding is earmarked by specific donors for specific projects — meaning donors, not elected governments, effectively set the agenda. The Gates Foundation has become WHO’s single largest funder, having contributed $5.5 billion between 2000 and 2024, with over half directed toward vaccines and polio programs. Following the United States’ announced withdrawal in 2025, this concentration of influence has grown even more pronounced. The May 2025 WHO Pandemic Agreement further cemented this new financial architecture, raising serious questions about whose interests global pandemic preparedness funding ultimately serves.

The REPPARE Project — short for Rethinking Evidence, Policy, and Pandemic Response Evaluation — is an independent research initiative based at the University of Leeds. Led by Dr. David Bell, a physician and former WHO specialist in tropical medicine, and Professor Garrett Brown, Chair of Global Health Policy, REPPARE conducts forensic reviews of the evidence used by institutions like the WHO, World Bank, and G20 to justify pandemic preparedness funding decisions. Their findings have repeatedly shown that institutional claims often contradict the very sources they cite — including inflated COVID death counts, overstated disease risks, and systematic undercounting of lockdown-related harms. REPPARE is supported by the Brownstone Institute and operates with full editorial independence.

✓ Pandemic preparedness funding has grown to $30-40 billion annually, 10x WHO’s total budget ✓ Gates Foundation is now WHO’s largest single funder, directing 50%+ toward vaccines ✓ WHO’s priority disease list contains no pathogen that has killed more than a few thousand people ✓ Global burden of disease data is systematically inflating COVID deaths while minimizing lockdown harms ✓ Public-private partnerships direct taxpayer money toward pharmaceutical profits ✓ The REPPARE Project provides independent evidence review of pandemic industry claims ✓ Real health threats (malaria, TB, sanitation) remain underfunded while theoretical pandemics absorb resources

The REPPARE Project (Rethinking Evidence, Policy, and Pandemic Response Evaluation) operates from the University of Leeds, providing independent analysis of pandemic preparedness policies and claims. Dr. David Bell, a physician specializing in tropical medicine with extensive WHO experience, leads the evidence review alongside Professor Garrett Brown, Chair of Global Health Policy at Leeds. Their work is supported by Brownstone Institute and conducted with complete independence—a rarity in today’s funding environment where research outcomes are often predetermined by donor interests.

The Trump administration’s approach to small business policy represents a fundamental shift from traditional Washington thinking. In a revealing interview, Casey Mulligan—former chief economist at the White House Council of Economic Advisers and current chief counsel at the SBA’s Office of Advocacy—provides unprecedented insights into how Trump deregulation helps small business owners navigate an increasingly complex economic landscape.

• Introduction: Trump’s Small Business Revolution in Action
• SBA Office of Advocacy Casey Mulligan Interview: Key Revelations
  • From White House Economist to Small Business Champion
  • Trump vs Biden Small Business Loan Approvals: The Real Numbers
• Small Business Regulatory Compliance: The Hidden Burden
  • COVID-19’s Devastating Impact on Main Street
  • The Real Cost of Regulatory Complexity
• Small Business Regulatory Reform Trump Administration: A Systematic Approach
  • Deregulation as Economic Strategy
  • Federal Reserve Impact on Small Business: The Hidden Connection
• Trump Small Business Tax Reform: Simplification vs. Complexity
  • The Annual Tax Season Nightmare
  • Progressive vs. Flat Tax: What Small Businesses Actually Need
• Small Business Succession Planning: The Overlooked Crisis
  • When Business Knowledge Dies with the Owner
  • Business Continuity Solutions
• SBA Reform Under Trump: Advocacy Over Bureaucracy
  • Shifting from Regulation to Representation
  • Real-World Policy Implementation
• Economic Policy Analysis: Expert Class Failures and Populist Solutions
  • Why Traditional Experts Keep Getting It Wrong
  • Trump as Listener-in-Chief
• Tariff Strategy: Revenue Mix vs. Protectionism
  • Understanding the Actual Policy
  • Historical Context and Future Implications
• Bureau of Labor Statistics Accuracy: Market Impact and Reform Needs
  • The Trillion-Dollar Data Problem
  • Proposed Solutions
• Conclusion: The Future of Small Business Under Trump’s Economic Vision

As someone who served in Trump’s first administration and continues in the second, Mulligan brings both academic expertise and real-world small business experience to his analysis of current economic policies.

As Mulligan notes in promoting his book “You’re Hired,” these insights provide information “you’re not going to get anywhere else.”

During the interview, Mulligan explains his transition from serving as chief economist at the White House Council of Economic Advisers in Trump’s first term to his current role as chief counsel at the SBA’s Office of Advocacy. This unique career path provides him with both macro-economic perspective and ground-level understanding of small business challenges.

“Small businesses are at quite a disadvantage in Washington. They don’t have lobbying shops,” Mulligan observes, highlighting why dedicated advocacy becomes crucial for protecting Main Street America’s interests.

The interview reveals significant differences in how the current administration approaches small business support compared to previous policies. While specific loan approval statistics weren’t detailed in the conversation, Mulligan’s role at the SBA’s Office of Advocacy positions him at the center of these critical decisions.

Mulligan’s personal experience during the pandemic illustrates how regulatory policies can make or break small businesses. Operating both a medical practice and real estate properties, he witnessed firsthand how lockdown policies favored large corporations while devastating smaller enterprises.

“Storefronts had this big challenge of somehow surviving without customers,” he explains, while noting that companies like Amazon thrived during the same period. This disparity highlights the importance of regulatory policies that consider small business realities rather than one-size-fits-all approaches.

Small business regulatory compliance extends far beyond simple rule-following. The complexity of current systems forces business owners to spend valuable time and resources on bureaucratic requirements rather than growth and innovation. Mulligan’s experience running multiple businesses provides concrete examples of these challenges.

The Trump administration’s small business regulatory reform goes beyond simple rule elimination. Mulligan explains that the approach involves strategic analysis of which regulations genuinely protect consumers and workers versus those that primarily serve bureaucratic purposes.

“Deregulation was a big part of his goal in the first term and it’s just as big a goal for him in the second term,” Mulligan notes, emphasizing the continuity of this policy priority.

During the interview, Mulligan discusses how Federal Reserve policies disproportionately affect small businesses through interest rate decisions that may be influenced by political timing rather than economic fundamentals. This insight reveals another layer of how Washington policies impact Main Street differently than Wall Street.

Mulligan’s candid description of his personal tax preparation experience resonates with millions of small business owners: “Whenever I do tax season, it’s like I have to drop everything else.” This reality highlights why Trump small business tax reform focuses on simplification rather than just rate adjustments.

The current system’s complexity forces even sophisticated business owners to rely on software like TurboTax, creating what Mulligan calls “a big black box” where business owners input data without understanding the underlying calculations.

The interview explores how different tax structures affect small businesses practically rather than theoretically. Mulligan notes that even under flat tax systems, high earners would still contribute significantly more in absolute terms while dramatically reducing administrative burdens for everyone.

One of the most poignant examples Mulligan shares involves a security contractor who died suddenly, taking all business knowledge and customer relationships with him. “Everything went with him like all the knowledge that he had, all the customers, whole thing just shuttered,” he explains.

This anecdote illustrates a widespread problem in small business succession planning that affects thousands of enterprises annually. The lack of proper succession mechanisms destroys both economic value and employment opportunities.

Mulligan’s experience with a startup called “Gain Street” attempted to address business continuity challenges by providing systematic approaches to knowledge transfer and customer relationship preservation. While his particular venture didn’t succeed, the underlying need remains critical for small business ecosystem health.

The transformation of SBA priorities under Trump’s leadership emphasizes advocacy over administrative burden. Mulligan’s role exemplifies this shift—rather than adding more regulations, the focus turns to representing small business interests in policy discussions across all government agencies.

This approach recognizes that small businesses don’t need more government programs; they need government to understand and consider their perspectives when crafting policies.

The interview reveals how academic economic theory often fails to translate into practical small business solutions. Mulligan’s combination of University of Chicago economic training and hands-on business experience allows him to bridge this gap effectively.

Mulligan identifies a pattern of expert class failures extending from narcotics policy to COVID response to economic forecasting. These failures particularly harm small businesses, which lack resources to adapt quickly to misguided policies.

“The rise of populist politics stems partly from failures of the expert class,” he explains, noting that these aren’t theoretical failures but practical disasters affecting real businesses and real people.

The interview emphasizes Trump’s unusual approach to policy development: active listening to ordinary Americans rather than relying exclusively on expert recommendations. “Time and time again, he listens and if you pay attention, you can see a few days later, weeks later, months later that he really did listen and remember,” Mulligan observes.

Media coverage often mischaracterizes Trump’s tariff policies as purely protectionist measures. Mulligan clarifies that the actual Republican platform, written by Trump himself, focuses on changing America’s revenue mix rather than economic isolation.

The strategy involves using tariffs as leverage tools while potentially reducing reliance on complex income tax systems that disproportionately burden small businesses with compliance costs.

Mulligan notes that tariffs served as the government’s primary revenue source before the Woodrow Wilson era introduction of income taxes. The current approach considers returning to revenue diversification while maintaining modern economic integration.

The interview reveals serious accuracy issues with Bureau of Labor Statistics surveys that affect trillions of dollars in market decisions. Frequent revisions to key economic indicators create uncertainty that particularly affects small businesses unable to hedge against data volatility.

“When you have data that’s unreliable, it gets to be very noisy. So, you have to revise it a lot,” Mulligan explains, noting how this creates appearance problems regardless of actual intent.

Reform efforts focus on improving survey methodologies to reduce revision frequency and increase initial accuracy. This would provide more stable economic indicators for both policy decisions and market operations.

Casey Mulligan’s insights from the interview reveal a comprehensive approach to small business support that goes far beyond traditional government programs. The focus on deregulation, tax simplification, genuine advocacy, and data accuracy represents a systematic effort to level the playing field between small businesses and large corporations.

The success of these policies will be measured not in government program statistics but in the real-world success of America’s millions of small business owners who form the backbone of the nation’s economy. As Mulligan notes in promoting his book “You’re Hired,” these insights provide information “you’re not going to get anywhere else.”

For small business owners navigating today’s complex economic environment, understanding these policy directions becomes crucial for strategic planning and long-term success. The Trump administration’s populist approach to economic policy prioritizes listening to business owners rather than imposing theoretical solutions from Washington experts.

About the Source: This analysis is based on an in-depth interview with Casey Mulligan, chief counsel at the SBA’s Office of Advocacy and former White House Council of Economic Advisers chief economist. His unique perspective combines academic economic expertise with practical small business ownership experience.

Related Topics: Small business regulatory compliance, Trump economic policy analysis, SBA loan program changes, Federal Reserve impact on small business, small business succession planning

The fractures in American politics have become increasingly visible, and Dr. Andrew Huff has emerged as a critical voice advocating for systemic reform. His insights touch on political unity, public health, governance, and the role of prominent figures like Tulsi Gabbard and Robert F. Kennedy Jr. In this article, we explore Huff’s perspectives on rebuilding public trust and reforming institutions.

• Unity Coalition and Political Alignments
  • The Role of Kennedy Democrats and the MAGA Movement
• Robert F. Kennedy Jr.’s Public Health Advocacy
  • The Importance of Gold-Standard Science
• Tulsi Gabbard’s Appointment as Director of National Intelligence
  • From Military Service to National Leadership
• Critique of Federal Agencies and Decentralization
  • Improving Accountability Through Decentralization
• Pandemic Response and Medical Freedom
  • Distributed Systems for Public Health Resilience
• Pharmaceutical Oversight and Reform
  • The Need for Rigorous Regulatory Standards
• Autism and Environmental Exposures
  • The Role of Epidemiological Studies
• Military and Governance Perspectives
  • Self-Earned Democracy in Practice
• Dr. Andrew Huff’s Credentials and Book
  • Exploring Pandemic Origins
• Future Policy Directions
  • Building a Vision for the Next Administration
• Conclusion
• FAQs
• Who is Dr. Andrew Huff?
• Why are RFK Jr. and Tulsi Gabbard important figures in U.S. politics?
• What is the significance of decentralizing federal agencies?
• How does Dr. Huff address vaccine-related concerns?
• What are the main takeaways from The Truth About Wuhan?

Efforts to bring together disparate political groups are at the heart of Dr. Huff’s discussions. The potential for collaboration between Kennedy Democrats and the MAGA movement highlights the importance of unity in future elections.

While these groups often differ in priorities, they share common goals like restoring trust in governance and safeguarding individual freedoms. Overcoming factionalism within these coalitions will be key to achieving meaningful reform.

RFK Jr. has been a staunch advocate for evidence-based practices in public health. He has consistently called out pharmaceutical companies for prioritizing profits over transparency.

Kennedy emphasizes the need for rigorous scientific validation to address public health crises. His push for transparency aims to restore trust in institutions like the CDC and FDA.

Tulsi Gabbard’s leadership in national security reflects her commitment to fostering collaboration across intelligence agencies.

Gabbard’s background as a military officer and her dedication to public service uniquely position her to tackle complex security challenges.

Dr. Andrew Huff strongly advocates for decentralizing federal agencies like the Department of Health and Human Services (HHS) and the Department of Education. He argues that their large size and centralized nature often lead to inefficiencies, bureaucratic delays, and lack of accountability.

When governance is localized, it becomes easier to tailor policies to the unique needs of communities. For example, healthcare systems in rural areas require a different approach than urban centers. By reducing the power of federal agencies and delegating responsibilities to state and local governments, we can achieve better outcomes and empower citizens to participate more directly in governance.

The centralized response to the COVID-19 pandemic revealed critical flaws in the system. Dr. Huff critiques the overreliance on mRNA vaccines and centralized countermeasures, arguing for a more distributed and resilient approach.

A decentralized system for pandemic preparedness would involve local production of medical supplies, diversified vaccine options, and community-driven health initiatives. This would reduce reliance on global supply chains and ensure communities are better prepared to handle future crises.

Dr. Huff highlights the urgent need for stricter regulation of pharmaceutical companies. He points out that the current system often prioritizes profit over public health.

Pharmaceutical oversight should include robust validation of clinical trials, transparency in research funding, and ethical considerations in drug approval processes. Public health policies, such as vaccine mandates, must be based on sound science to maintain trust.

One of the more controversial topics Dr. Huff discusses is the potential link between autism, vaccines, and environmental factors. While he doesn’t claim causation, he emphasizes the need for comprehensive research.

Large-scale, unbiased studies are crucial for addressing public concerns. By investigating environmental exposures alongside genetic and other factors, scientists can better understand autism’s causes and improve prevention strategies.

Dr. Huff’s reflections on governance are informed by his military experiences, particularly in conflict zones like Iraq. He draws lessons from these settings to advocate for stronger democratic principles in the U.S.

Huff emphasizes that democracy cannot be imposed externally; it must be nurtured from within. His observations in Iraq underline the importance of community-driven governance and the dangers of top-down approaches.

Dr. Huff’s background in epidemiology and public health lends credibility to his insights. His book, The Truth About Wuhan, delves into the origins of the COVID-19 pandemic and challenges the official narratives.

In his book, Huff provides evidence that raises questions about the role of global health organizations and governments in managing pandemic responses. He calls for transparency and accountability in uncovering the truth.

Dr. Huff envisions a future where public health, education, and governance are reformed to better serve the American people. He sees leaders like RFK Jr. and Tulsi Gabbard playing pivotal roles in this transformation.

To rebuild public trust, the next administration must focus on transparency, evidence-based policies, and unity. Dr. Huff’s proposals aim to address systemic issues and foster collaboration across political divides.

Dr. Andrew Huff’s insights shed light on the deep fractures within American politics and governance. By advocating for decentralization, transparency, and evidence-based practices, he outlines a path to rebuild public trust. Leaders like Tulsi Gabbard and RFK Jr. are poised to drive these reforms, offering hope for a more united and accountable future.

Dr. Andrew Huff is a public health expert and epidemiologist known for his work on pandemic origins and systemic reform.

RFK Jr. advocates for transparency in public health, while Tulsi Gabbard’s leadership focuses on national security and intelligence reform.

Decentralization aims to improve efficiency and accountability by empowering local governance.

He emphasizes the need for rigorous scientific validation and ethical oversight in public health policies.

The book explores the origins of the COVID-19 pandemic and calls for greater transparency in addressing public health challenges.

What if the very policies designed to protect us during a crisis were the ones causing us harm? Economist Sanjeev Sabhlok believes this was the case during the COVID-19 pandemic. In his sharp critique, Sabhlok exposes the cracks in public health policies and highlights the need for economics to play a bigger role in decision-making. Let’s dive into his thought-provoking insights and explore how we can rethink the intersection of public health and economics.

• The Pandemic’s Public Policy Flaws
• Economics and Trade-Offs: A Missed Opportunity
• The Utilitarian Perspective
• Lockdowns and Their Collateral Damage
• Critique of Quarantine as a Universal Tool
• Transparency in Public Health Policy
• Classical Liberalism and Accountability
• Economists’ Shortcomings During the Pandemic
• Long-Term Impacts of Policy Failures
• A Call for Reform in Public Health
• Economics as a Tool for Better Public Policy
• Key Lessons from Sanjeev Sabhlok
• Why This Matters Now
• Conclusion
• FAQs

Sabhlok points to a glaring oversight in pandemic policy-making: the lack of cost-benefit analysis. Governments worldwide implemented sweeping measures, like lockdowns, without fully understanding their consequences. Decisions made in panic often replaced reasoned, data-driven approaches, leading to avoidable harm.

Economists excel at weighing trade-offs—choosing the best option among competing alternatives. However, during the pandemic, this crucial perspective was largely absent. Sabhlok argues that public health officials failed to consider the broader ramifications of their decisions, such as the economic and social costs of prolonged restrictions.

At the heart of Sabhlok’s argument lies the principle of utilitarianism, which seeks to maximize the greatest good for the greatest number. Yet, pandemic policies often ignored this foundational idea. Lockdowns, while aimed at saving lives, neglected their devastating impacts on mental health, job security, and social cohesion.

Lockdowns were hailed as a necessary evil, but their long-term consequences tell a different story. Rising rates of depression and anxiety, the collapse of small businesses, and the erosion of community ties are just a few examples of the damage inflicted. Sabhlok highlights that these costs should have been weighed more carefully.

Quarantine policies have a long history, but their efficacy is far from universal. Sabhlok criticizes their widespread application during COVID-19, arguing that they often ignored human behavior and logistical realities. Instead of curbing the virus effectively, such policies created unintended ripple effects.

Public health must strive for the same level of rigor as physics or mathematics, Sabhlok insists. Policies should be transparent and rooted in proven methodologies. However, during the pandemic, a lack of openness allowed harmful decisions to persist, undermining public trust.

Sabhlok’s classical liberal philosophy emphasizes skepticism of authority and accountability in governance. He believes that questioning public health mandates and seeking practical, evidence-based solutions could have prevented many policy missteps.

Even economists, Sabhlok admits, faltered during the crisis. Many abandoned their principles, succumbing to the prevailing panic. However, he emphasizes that tools like cost-benefit analysis remain invaluable for guiding public health responses.

The scars of pandemic policies run deep. Beyond immediate health concerns, policies like lockdowns have left lasting damage on mental well-being, economic stability, and social structures. Sabhlok stresses the importance of considering these long-term impacts in future decision-making.

Sabhlok calls for a fundamental shift in public health, urging policymakers to embrace transparency, rationality, and accountability. By learning from the mistakes of the past, society can build a more effective and equitable framework for addressing future crises.

Integrating economic principles into public health can lead to more balanced and effective policies. By considering trade-offs and optimizing outcomes, governments can avoid the pitfalls of one-size-fits-all solutions.

Sabhlok’s insights offer a roadmap for improving pandemic preparedness. From prioritizing cost-benefit analysis to fostering open dialogue, his ideas challenge us to rethink how we approach public health emergencies.

As the world continues to grapple with the aftermath of COVID-19, Sabhlok’s critique is more relevant than ever. By addressing the flaws exposed during the pandemic, we can ensure that future crises are met with resilience and reason.

Sanjeev Sabhlok’s bold ideas challenge conventional wisdom and call for a paradigm shift in public health. By embracing principles of transparency, accountability, and economic reasoning, we can build a society that not only survives crises but thrives in their aftermath.

An economist and former bureaucrat, Sabhlok critiques pandemic policies through the lens of economics and public health.

Sabhlok argues that policies like lockdowns lacked cost-benefit analysis and caused more harm than good.

Utilitarianism seeks to maximize overall well-being, a principle Sabhlok believes was ignored during COVID-19.

Transparency fosters trust and ensures that policies are grounded in rigorous, evidence-based methodologies.

Integrating economics into public health, prioritizing accountability, and learning from past mistakes can guide better crisis responses.

The COVID-19 pandemic not only brought unprecedented challenges but also exposed how deeply intertwined media, government, and pharmaceutical interests can manipulate public narratives. John Davidson’s documentary, Epidemic of Fraud, dives into this troubling phenomenon, revealing how early treatments like hydroxychloroquine and ivermectin were suppressed, not for scientific reasons, but for political and financial gain.

• Media Manipulation During COVID-19
  • The Role of Media in Shaping the Pandemic Narrative
  • Suppression of Early Treatments: Hydroxychloroquine and Ivermectin
  • Dismissal of These Treatments Without Scientific Backing
  • The Political Motivations Behind Discrediting Certain Treatments
• Government and Pharmaceutical Influence
  • Regulatory Capture: A Dangerous Alliance
  • The Intertwining of Public Health Agencies and the Pharmaceutical Industry
  • How This Connection Eroded Public Trust
• The Role of Donald Trump in COVID-19 Treatment Controversies
  • Trump’s Endorsement of Hydroxychloroquine
  • How the Endorsement Became Politically Charged
  • Impact on the Credibility of the Treatment
• Davidson’s Personal Journey in Uncovering the Fraud
  • From Marketing in Hollywood to Exposing the Pandemic’s Misinformation
  • What Inspired Davidson to Create Epidemic of Fraud
• Big Pharma’s Role in Misinformation
  • Pharmaceutical Advertising’s Influence on Broadcast Media
  • Financial Motives Behind the Vaccine Narrative
  • Vaccines as a “Ponzi Scheme”
  • Media’s Role in Promoting Vaccines and Suppressing Alternative Treatments
• Regulatory Capture in the Pandemic
  • What is Regulatory Capture?
  • How the FDA and CDC Serve the Interests of Big Pharma
  • Examples of Regulatory Failure During the Pandemic
• The Politicization of Medicine
  • The Damage Done by Politicizing Health Decisions
  • The Public’s Growing Distrust in Medical Institutions
  • How Media Narratives Influenced Medical Policies
• Hydroxychloroquine and Ivermectin: Safe, Yet Suppressed
  • The History of These FDA-Approved Drugs
  • Why Were These Treatments Suddenly Deemed Dangerous?
  • The Conflict Between Right to Try Legislation and Pandemic Restrictions
• The Call for Transparency in Medicine
  • Davidson’s Appeal for Honesty in the Medical Field
  • The Need to Restore Public Trust
  • How to Fight Back Against Misinformation
• Conclusion
• FAQs
  • Why did John Davidson create Epidemic of Fraud?
  • What are hydroxychloroquine and ivermectin?
  • What is regulatory capture, and how did it affect the COVID-19 response?
  • How did Donald Trump’s endorsement impact the public perception of COVID-19 treatments?
  • What is the current status of alternative COVID-19 treatments like hydroxychloroquine and ivermectin?
• Related Articles

The media, throughout the COVID-19 pandemic, played a crucial role in shaping public perception. Daily broadcasts bombarded audiences with fear-driven messages, reinforcing the idea that only vaccines could save us. Davidson’s documentary highlights how this one-sided narrative left little room for alternative perspectives or treatments. The result? A public increasingly divided and confused about what to believe.

Hydroxychloroquine and ivermectin, once hailed as potential game-changers, were quickly dismissed by the media. Why? Davidson reveals that this dismissal wasn’t backed by strong scientific evidence but was instead driven by political motivations.

Despite both drugs being FDA-approved and widely used for decades, they were labeled as dangerous during the pandemic. Davidson’s documentary asks the difficult questions: Why was something safe for decades suddenly demonized? The answer lies in the intersection of politics and media influence.

Davidson argues that Donald Trump’s endorsement of hydroxychloroquine played a significant role in its downfall. The media’s anti-Trump bias extended to anything he supported, including this treatment, transforming it from a potential remedy into a politically toxic issue. This was a classic case of politics overshadowing science.

One of the most alarming revelations in Davidson’s film is the concept of regulatory capture. This occurs when regulatory agencies, like the FDA and CDC, become so enmeshed with the industries they’re supposed to regulate that their judgments are no longer impartial.

Davidson presents a compelling case that these agencies, particularly during the pandemic, were more concerned with serving Big Pharma’s interests than protecting public health. This cozy relationship led to policies that often favored pharmaceutical profits over patient safety.

As Davidson points out, the erosion of public trust was inevitable. When the agencies tasked with keeping us safe appear to be more invested in corporate profits, people naturally begin to question the integrity of their recommendations.

Donald Trump’s endorsement of hydroxychloroquine may have been well-intentioned, but it had disastrous consequences for the drug’s credibility.

Davidson humorously notes that “Donald Trump and hydroxychloroquine had an affair, and that was their baby.” This politically charged environment led to the treatment being judged not on its merits, but on who endorsed it.

Had Trump never mentioned the drug, hydroxychloroquine might have received a fairer scientific evaluation. Instead, it became a symbol of partisan warfare, with facts taking a backseat to political allegiances.

John Davidson wasn’t always a documentary filmmaker. His background in Hollywood marketing gave him a unique lens through which to view the pandemic. He knew firsthand how narratives are shaped and how manipulation works in media. The sudden censorship and media manipulation during the pandemic sparked his curiosity.

Watching media outlets deliberately suppress information about early treatments, Davidson knew he couldn’t remain silent. His journey into the “epidemic of fraud” began, driven by a sense of urgency to expose the truth.

One of Davidson’s boldest claims is that pharmaceutical advertising needs to be banned from broadcast media. He argues that these advertisements, which flood the airwaves, have skewed the media’s priorities and clouded objective reporting.

Davidson points to the financial incentives that led to the aggressive promotion of vaccines while dismissing alternative treatments.

Davidson compares the vaccine push to a Ponzi scheme, where the goal is to keep the money flowing, regardless of the consequences. This assertion may seem extreme, but he backs it with compelling evidence that challenges the motivations behind the widespread vaccine campaign.

The media’s cozy relationship with Big Pharma ensured that vaccines were treated as the only viable solution, with alternative treatments relegated to conspiracy theory status.

Regulatory capture is when agencies tasked with regulating industries become subservient to the very businesses they’re supposed to oversee.

During the pandemic, Davidson argues that regulatory capture was on full display. The FDA and CDC seemed more concerned with protecting pharmaceutical interests than public health.

From fast-tracking vaccines to dismissing early treatments, Davidson provides a thorough examination of how regulatory agencies failed the public during the pandemic.

By turning health issues into political battlegrounds, the media and government have made it harder for people to trust legitimate medical advice.

This distrust has far-reaching consequences, as people now question even routine medical recommendations.

The media’s selective coverage and bias influenced medical policy decisions, pushing treatments like hydroxychloroquine and ivermectin to the sidelines.

Hydroxychloroquine and ivermectin were both FDA-approved long before COVID-19 and have proven safety records.

Davidson’s documentary raises the question: why were these drugs, which had been safely used for decades, suddenly labeled as dangerous?

The irony is that while the Right to Try law allows terminally ill patients access to experimental treatments, COVID-19 patients were denied that same right for these FDA-approved drugs.

Davidson’s film is a call to action for more transparency and honesty in medicine. He believes the pandemic has shown just how compromised the system has become.

Rebuilding public trust will require a complete overhaul of how medical information is communicated and regulated.

Davidson urges the public to remain vigilant and question the narratives being presented. By demanding transparency, we can prevent future “epidemics of fraud.”

John Davidson’s Epidemic of Fraud is a wake-up call to anyone who values truth and transparency. His documentary sheds light on the murky world of media manipulation, government overreach, and pharmaceutical influence during the COVID-19 pandemic. By exposing the suppression of early treatments and the politicization of health decisions, Davidson highlights the need for a major shift in how we approach medicine and public health.

John Davidson was inspired to create the documentary after witnessing media manipulation and censorship of alternative COVID-19 treatments, leading him to investigate further.

Hydroxychloroquine and ivermectin are FDA-approved medications that were considered potential treatments for COVID-19 but were heavily suppressed during the pandemic.

Regulatory capture occurs when regulatory agencies become too closely tied to the industries they regulate. During COVID-19, Davidson argues that agencies like the FDA and CDC served pharmaceutical interests rather than the public.

Trump’s endorsement of hydroxychloroquine politicized the drug, causing it to be discredited by the media and public health agencies, regardless of its potential benefits.

While these treatments are still being studied, their use during the pandemic was largely suppressed, and they remain controversial despite ongoing research.

Andrew Bridgen, a former Member of Parliament in the UK, offers a chilling narrative of his sudden and mysterious political downfall. With an election result that saw his vote share plummet from 63% to a mere 3%, Bridgen unpacks a series of events that he believes are not only suspicious but also indicative of a broader pattern of government overreach, media complicity, and corporate interference in the democratic process. This article dives into Bridgen’s claims, covering topics like election irregularities, vaccine controversies, selective law enforcement, and the erosion of civil liberties.

• The Election Shock: Bridgen’s Unexplained Defeat
• Discrepancies in Vote Count
• The Role of Media Silence
• The Vaccine Debate: Bridgen’s Critique of Government Overreach
• Government Overreach in Public Health
• Selective Scrutiny and Media Accountability
• Immigration and Two-Tier Law Enforcement
• Two-Tier Law Enforcement
• Erosion of Civil Liberties
• Conclusion
• FAQs
• Related Articles

Andrew Bridgen’s political career took an unexpected turn during his most recent election. After securing over 63% of the vote in his previous races, Bridgen found himself facing an unbelievable result—his vote share dropped to just 3%. According to Bridgen, the result defied all logic. He was a seasoned politician with strong community ties, yet somehow, in a span of one election cycle, he was seemingly erased from the political scene.

This sharp decline raised many eyebrows, especially when combined with reports of suspicious activities. Election officials resigned en masse, and delays in ballot counting were left unexplained. For Bridgen, these irregularities were more than just minor administrative hiccups—they pointed to something far more troubling.

The oddities didn’t stop at the results. Bridgen noted that the resignation of key election officials during the process only added to the mystery. Delays in counting ballots, a process that should have been straightforward, fueled his suspicions. “Wherever I go, people tell me they voted for me,” he stated, reflecting on the apparent disconnect between public support and the election outcome.

In a political climate where media outlets often jump on high-profile losses, Bridgen was puzzled by the eerie silence surrounding his defeat. If his political downfall had been a legitimate and clear-cut rejection by the electorate, he expected the media to revel in his misfortune. But instead, there was barely a whisper.

For Bridgen, this media silence was as concerning as the election itself. “If I had really been humiliated at the polls, the media would have celebrated it. But there was nothing,” he remarked. It’s in this absence of coverage that he sees something more sinister—a concerted effort to brush his defeat under the rug.

Bridgen hasn’t been shy about his criticism of the government’s handling of the COVID-19 pandemic. His views, particularly on the vaccine rollout, have been controversial, to say the least. Bridgen argues that the government’s push for mRNA vaccines was more about corporate profits than public health.

For Bridgen, the pandemic exposed the troubling ties between governments and large corporations. He believes that pharmaceutical companies, in collaboration with global organizations like the WHO, played an outsized role in shaping policies that were supposed to protect public health but ended up prioritizing profits instead.

“Rishi Sunak and Keir Starmer are both owned by the World Economic Forum. They don’t serve the people,” he claimed, suggesting that political leaders were more beholden to supranational organizations than to their own constituents.

Bridgen draws a parallel between his own situation and other high-profile scandals, such as Jeffrey Epstein’s case. He points out that, in some instances, the media and authorities seem to conveniently ignore glaring issues, while in others, they apply intense scrutiny. According to Bridgen, this selective attention erodes public trust in both the media and government.

Everywhere you go, there are cameras—except when Epstein ‘decides’ to kill himself,” Bridgen said, using Epstein’s case to highlight what he perceives as a deliberate lack of accountability.

The growing issue of immigration in the UK is another topic Bridgen has tackled. He points out that immigration policies have exacerbated social tensions and contributed to a housing shortage. According to him, the government has been reluctant to address the concerns of the working class, further deepening divisions.

Bridgen also touched on what he sees as a two-tier system of law enforcement, where certain communities receive more lenient treatment. As an example, he recalled an incident where Muslim men armed with machetes in Birmingham were simply asked to leave their weapons in a mosque and go home, instead of facing stricter legal consequences.

Throughout his account, Bridgen paints a stark picture of modern governance—where governments use crises to erode civil liberties under the guise of public safety. He believes that the pandemic was used as a pretext to strip away freedoms that are only now being questioned.

Andrew Bridgen’s account of his sudden political demise and the broader issues he raises about governance, media complicity, and corporate interests paint a troubling picture of the state of modern democracy. Whether his claims are a reflection of deep-rooted systemic issues or a personal narrative shaped by his defeat, they open up critical questions about accountability, transparency, and the influence of power in today’s political landscape.

Bridgen cited the en-masse resignation of election officials and unexplained ballot delays as key irregularities.

He believes the rollout was driven by corporate interests and that the vaccines are neither safe nor effective.

Bridgen argues that the media’s silence was intentional, reflecting a broader pattern of selective scrutiny.

He refers to unequal policing, where certain communities face leniency while others face harsher enforcement.

He believes that political leaders are heavily influenced by the WEF, undermining democratic principles.

In the wake of the COVID-19 pandemic, societies around the globe are grappling with the consequences of not just a health crisis, but also the ripple effects on economies, institutions, and social structures. One thought-provoking analysis on this phenomenon comes from Dr. Michaéla Schippers, who, along with her co-authors John P. A. Ioannidis and Matthias W. J. Luijks, introduced the idea of a “Death Spiral Effect.” This concept paints a grim picture of how societal responses to crises can lead to a rapid decline, but also offers hope through solutions that can reverse the trend.

The paper “Is Society Caught Up in a Death Spiral? Modeling Societal Demise and Its Reversal” is more than just a theoretical exercise—it’s a bold call to action. The authors argue that unless drastic measures are taken, society risks a continued downward spiral. But what exactly is this “Death Spiral Effect,” and how can we avoid it? Let’s dive into Michaéla Schippers’ detailed analysis and uncover the potential path forward.

• The “Death Spiral Effect” Explained
• The Role of the COVID-19 Pandemic
• Consequences of Panic-Driven Decisions
• Groupthink and Its Impact on Society
• The “Ant-Like” Chaos in Society
• Hunger and Economic Disparity
• Erosion of Trust in Institutions
• Pressure to Conform
• Turnaround Leadership: A Path to Reversal
• Selfless Leadership as a Solution
• Signs of Societal Collapse
• Breaking the Downward Spiral
• Building a Resilient Society
• Conclusion
• FAQs
  • What is the “Death Spiral Effect”?
  • How did the COVID-19 pandemic contribute to societal decline?
  • What role does groupthink play in societal collapse?
  • What is turnaround leadership?
  • How can we reverse the societal death spiral?
• Related Articles

The “Death Spiral Effect” is a theoretical model that highlights how poorly managed crises can send societies into a self-perpetuating cycle of decline. This model applies to various types of societal disruptions, but Michaéla Schippers places a significant emphasis on the pandemic as a trigger. The concept revolves around the idea that crisis responses, such as lockdowns and restrictions, can exacerbate existing issues, creating a cascading effect that spirals out of control.

In the case of the pandemic, rather than stabilizing societies, many of these decisions deepened social, economic, and political divides. Each decision, made in the name of public health, resulted in unintended consequences, ranging from rising inequality to eroding trust in institutions. It’s a cycle that, if left unchecked, can lead to societal collapse.

The global response to the COVID-19 pandemic was swift but, according to Dr. Schippers, often misguided. Governments around the world instituted lockdowns, closed schools, and implemented broad restrictions to curb the spread of the virus. While these measures may have had short-term benefits, Schippers argues that the long-term fallout has been disastrous.

Lockdowns, school closures, and restrictions did more harm than good,” Dr. Schippers states. Her critique is based on the ripple effects these actions have had on economies and societies at large. Hunger, mental health crises, and educational setbacks are just a few of the dire outcomes she highlights.

One of the key drivers of the Death Spiral Effect is the tendency for leaders to make decisions based on panic rather than thoughtful consideration. Panic-driven decisions tend to focus on immediate problems without fully assessing the long-term ramifications. As a result, societies face increasing inequality, loss of freedoms, and a growing mistrust in institutions.

For instance, the pandemic restrictions disproportionately affected lower-income families, who were more likely to lose their jobs, struggle with remote learning, and face food insecurity. Meanwhile, the wealth gap widened, as those with resources were better able to adapt to the new reality.

Another critical element in Schippers’ analysis is the phenomenon of groupthink. Groupthink occurs when societal pressures force individuals to conform to a particular narrative, suppressing dissenting opinions and alternative solutions. In the context of the pandemic, groupthink led to a narrow focus on certain outcomes, such as reducing infection rates, without considering the broader impacts on mental health, education, and the economy.

Schippers emphasizes that this environment of conformity stifled critical thinking and open debate, making it difficult to develop balanced, well-rounded responses to the crisis.

Dr. Schippers uses a vivid metaphor to describe the current state of society, likening it to “ants running around in chaos.” This analogy paints a picture of a society in disarray, where individuals are frantically trying to cope with the overwhelming challenges brought on by the pandemic and its aftermath.

The metaphor of ants evokes a sense of confusion and lack of direction. In this scenario, people are reacting to the immediate threats around them, but without any clear plan or strategy for long-term survival. The result is a society that appears to be running in circles, unable to escape the downward spiral.

One of the most alarming consequences of the pandemic response, according to Dr. Schippers, is the rise in global hunger. “Hunger has doubled since 2020,” she points out, referencing the growing number of people facing food insecurity as a result of economic instability. The pandemic’s impact on global supply chains, coupled with the economic downturn, has left millions more without access to basic necessities.

At the same time, economic inequality has deepened. Those who were already disadvantaged before the pandemic have found themselves in even more precarious situations, while the wealthiest segments of society have seen their fortunes grow.

As society continues to spiral downward, one of the most significant casualties has been trust in institutions. Governments, healthcare organizations, and other pillars of society have faced intense scrutiny, with many people feeling betrayed by what they perceive as inconsistent or poorly executed responses to the pandemic.

This erosion of trust has long-lasting implications. Without faith in institutions, society struggles to function cohesively, leading to further division and a breakdown of social order.

Another troubling aspect of the Death Spiral Effect is the pressure to conform. Throughout the pandemic, societal pressures to align with the dominant narrative were immense. Individuals who questioned the prevailing strategies or proposed alternative viewpoints were often silenced or marginalized.

Dr. Schippers warns that this kind of enforced conformity only deepens societal divisions, as it prevents open dialogue and the exploration of more innovative, effective solutions.

Despite the grim picture painted by the Death Spiral Effect, Dr. Schippers offers hope in the form of “turnaround leadership.” Turnaround leaders are those who can assess the situation with fresh eyes, free from the biases and pressures that contributed to the initial decline. These leaders must be willing to challenge the status quo and guide society toward a more sustainable path.

One of the core principles of turnaround leadership, according to Dr. Schippers, is selflessness. “We need leaders who are not in it for themselves,” she insists. True leaders, she argues, are motivated by a desire to serve the greater good, rather than personal gain.

Historical examples of selfless leadership, such as Nelson Mandela or Mahatma Gandhi, show how transformative leadership can bring about profound societal change.

Recognizing the signs of societal collapse is crucial for preventing it. Early indicators of a downward spiral include rising inequality, increasing civil unrest, and a breakdown in communication between institutions and the public. Dr. Schippers emphasizes the importance of being vigilant and acting before it’s too late.

Reversing the Death Spiral Effect requires a collective effort. Society must come together to break the cycle of decline, restore trust in institutions, and reduce inequalities. Open-mindedness, critical thinking, and a willingness to challenge groupthink are essential components of this effort.

Ultimately, Dr. Schippers advocates for a society where people can thrive, free from the fear of further decline. This involves rebuilding trust in institutions, reducing economic disparities, and fostering an environment where diverse perspectives are valued.

Dr. Michaéla Schippers’ analysis of societal decline serves as a wake-up call. The Death Spiral Effect is a stark reminder that panic-driven decisions and conformity can lead to a rapid and irreversible collapse. However, through selfless leadership, open dialogue, and a collective commitment to change, society can reverse this trend and build a more resilient future.

The “Death Spiral Effect” is a model that describes how poorly managed crises can lead to societal collapse through a cycle of worsening outcomes.

The pandemic led to panic-driven decisions like lockdowns and restrictions, which exacerbated inequality and eroded trust in institutions.

Groupthink suppresses dissent and critical thinking, leading to poor decision-making and further societal decline.

Turnaround leadership involves leaders who are willing to challenge the status quo and guide society toward recovery through selflessness and critical reassessment.

Reversing the death spiral requires collective action, reducing inequality, restoring trust in institutions, and fostering open dialogue.

In a riveting interview, Sanjeev Sabhlok, PhD, a public health-focused economist, provides a critical analysis of our responses to pandemics, comparing the restrained public and medical reaction to the 1918 influenza pandemic with the widespread panic induced by COVID-19. Despite today’s advanced medical science and communication technologies, and the absence of vaccines during the 1918 pandemic, the recent response seems disproportionately driven by panic. This observation raises pivotal questions about the evolution of public health strategies and the increasing influence of fear in policy-making.

• The Decline of Rationality in Modern Society
• Historical Perspective and Modern Health Crisis Management
• Neurological and Psychological Factors Influencing Panic
• The Call for Rational Public Health Policies
• Summary of Sanjeev Sabhlok’s Key Points
• Conclusion
• FAQs
• Related Articles

Sabhlok delves into the unintended consequences of societal progress on human rationality and our responses to crises. As humanity has advanced, becoming less reliant on the rudimentary survival skills that define the animal kingdom, there has been an ironic decline in our collective rationality, particularly evident in our handling of pandemics. This shift, marked by increased wealth, leisure, and a safety-first approach, has paradoxically heightened our susceptibility to panic, distancing us from the pragmatic, survival-oriented responses observed in other species.

Drawing on the insights of early public health pioneers, notably the sanitarians, Sanjeev Sabhlok critiques the modern tendency towards fear-driven health decisions. Centuries ago, sanitarians conducted rigorous analyses on the efficacy and dangers of quarantine, advocating for evidence-based interventions—a principle seemingly neglected in recent times. This historical perspective, juxtaposed with the handling of COVID-19, underscores the need for a reevaluation of our health crisis management tactics, suggesting that our current approach may be overshadowed by an era of safetyism, where society’s wealth and leisure have paradoxically led to heightened fear and risk aversion.

Sanjeev Sabhlok further explores the unique human propensity for panic, attributed to the deep linkages between the limbic system and the frontal lobe of the brain, which foster feedback loops of fear. This neurological insight, combined with an understanding of abnormal psychology, suggests that the modern human’s inclination towards panic is exacerbated by our capacity for imagination and exacerbated by our comparatively more comfortable, risk-averse lifestyles.

Contrasting the calm response to the 1918 pandemic and Sweden’s measured approach during COVID-19, the interview calls for a return to a more rational, evidence-based public health policy that prioritizes long-term well-being over immediate, reactionary measures. The goal is to encourage a societal and professional shift towards recognizing and mitigating irrational fears, fostering a culture where decisions are regularly revisited and reassessed in light of new evidence and perspectives.

In conclusion, Sanjeev Sabhlok’s analysis sheds light on the paradoxical nature of progress in modern society, where advancements in wealth and technology have ironically led to diminished rationality in our response to crises. By understanding the historical context and neurological underpinnings of panic, Sabhlok advocates for a return to evidence-based policymaking in public health, emphasizing the importance of rational decision-making in safeguarding societal well-being.

Sabhlok’s analysis highlights the paradox of progress, showcasing how modern advancements have led to decreased rationality in our response to crises, particularly pandemics.

Societies can mitigate panic by fostering a culture of rationality and evidence-based decision-making, promoting transparent communication, and providing accurate information from trusted sources.

Evidence-based policymaking ensures that decisions are grounded in empirical data and research, leading to more effective and efficient public health interventions.

Understanding the neurological basis of panic helps elucidate why humans react the way they do in crisis situations, informing strategies to mitigate panic and promote rational responses.

Individuals can contribute by staying informed from reputable sources, critically evaluating information, and advocating for evidence-based decision-making in their communities and workplaces.

• Interview with Russell L. Blaylock, M.D.
• Sanjeev Sabhlok: The Great Hysteria and The Broken State; Thoughts on economics and liberty
• Unmasking Public Health: Sanjeev Sabhlok’s “First Principles” -Test
• Coronavirus Conversation: It was just a pandemic phase you were going through
• Jessica Hockett Jonathan Engler enigma of rapid mortality surge NYC 2020.